首页> 外文期刊>Urology >Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
【24h】

Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.

机译:上尿路移行细胞癌手术治疗后膀胱内复发的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To identify risk factors for developing subsequent bladder cancer in patients undergoing surgical management of transitional cell carcinoma (TCC) of the upper urinary tract. METHODS: This study included 177 patients who were diagnosed as having clinically localized upper urinary tract TCC and thereafter underwent nephroureterectomy after exclusion of those with a previous and/or concurrent history of bladder cancer. Univariate and multivariate analyses using both the logistic regression model and the Cox proportional hazards model were carried out in these 177 patients to determine the risk factors for intravesical recurrence after nephroureterectomy. RESULTS: Of the 177 patients, 63 (35.6%) developed recurrent bladder cancer after a median interval of 7.5 months. Intravesical recurrence-free survival rates for these 177 patients at 1, 3, and 5 years were 75.7%, 63.7%, and 54.1%, respectively. Univariate analyses showed that patients with low-stage tumors and those with multifocal tumors were likely to undergo subsequent intravesical recurrence; however, there was no significant impact of other factors on subsequent intravesical recurrence, including age, tumor side, tumor location, surgical modality, operation time, management of the distal ureter, tumor grade, lymph node metastasis, microvascular invasion, lymphatic invasion, and margin status. Furthermore, pathologic stage and tumor multifocality were identified as independent predictors for the development of recurrent bladder cancer by multivariate analyses. CONCLUSIONS: The incidence of intravesical recurrence after nephroureterectomy for upper urinary tract TCC is comparatively high. It could be important to perform careful follow-up targeting intravesical recurrence for such patients after nephroureterectomy, particularly those with low-stage tumors and/or multifocal tumors.
机译:目的:确定接受上尿路移行细胞癌(TCC)手术治疗的患者继发膀胱癌的危险因素。方法:本研究包括177例被诊断为临床上尿路TCC的患者,随后在排除了既往和/或同时患有膀胱癌的患者之后接受了肾切除术。对这177位患者进行了logistic回归模型和Cox比例风险模型的单因素和多因素分析,以确定肾结膜切除术后膀胱内复发的危险因素。结果:在177例患者中,有63例(35.6%)在中位间隔7.5个月后发展为复发性膀胱癌。这177名患者在1、3和5岁时的膀胱内无复发生存率分别为75.7%,63.7%和54.1%。单因素分析表明,患有低期肿瘤和多灶性肿瘤的患者可能会随后发生膀胱内复发。但是,其他因素对随后的膀胱内复发没有显着影响,包括年龄,肿瘤侧,肿瘤位置,手术方式,手术时间,输尿管远端处理,肿瘤等级,淋巴结转移,微血管浸润,淋巴管浸润和保证金状态。此外,通过多变量分析,病理分期和肿瘤多灶性被确定为复发性膀胱癌发展的独立预测因子。结论:上尿路TCC肾切除术后膀胱内复发的发生率较高。对于肾结膜切除术后的这类患者,尤其是患有低期肿瘤和/或多灶性肿瘤的患者,进行针对膀胱内复发的仔细随访可能很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号